ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help

|
|
|
|

Trending News

Strengthening DNA to Prevent Inflammation, Heart Disease, Dementia and More

Magnesium: Widespread Deficiency with Deadly Consequences

Turmeric compound boosts regeneration of brain stem cells

The Most Powerful Natural Antioxidant Discovered to Date - Hydroxytyrosol

Culprits of Autism Identified: Toxins, Gut Bacteria, Nutritional Deficiencies, and Vaccines Made wit...

CoQ10: The Longevity Factor

Omega-3 Fatty Acids Increase Brain Volume

Optimal Prostate Defense Requires a Multi-Modal Strategy

Use of Broad-Spectrum Antibiotics Before Age 2 Associated with Obesity Risk

Extending Life and Fighting Disease with Resveratrol

 
Print Page
Email Article

New Study Finds High Prevalence of Chronic Fatigue Syndrome

  [ 112 votes ]   [ Discuss This Article ]
www.ProHealth.com • March 10, 2004


NCID Focus Volume 13 Number 1 Winter 2004 Focus on Viral and Rickettsial Diseases Population-based estimates of the occurrence of chronic fatigue syndrome (CFS) in Wichita, Kan., suggest that the disorder is a major public health problem, particularly among women, according to a published report by Division of Viral and Rickettsial Diseases (DVRD) scientists and their colleagues at private or medical institutions. (Arch Intern Med 2003; 163:1530-6) “When extrapolated to the US population, our estimates indicate that as many as 800,000 adults may have CFS. Fewer than 20% of these individuals will have been diagnosed with CFS and received medical attention for their fatiguing illness,” said William Reeves, chief, Viral Exanthems and Herpesvirus Branch and senior author of the report. Other CDC authors include Michele Reyes, Rosane Nisenbaum, Elizabeth Unger, and the late John Stewart. CFS is a debilitating illness for which there is no known cause or cure. Determining how many people have CFS has been difficult because of researchers’ inconsistent use of case-defining criteria and the lack of reliable laboratory tests for diagnosing the illness. To estimate baseline prevalence and 1-year incidence of CFS, Dr. Reeves and colleagues conducted a 4-year study in Wichita, Kansas, which has a population with demographic features (e.g., age, sex, race, ethnicity, income) similar to those of the US general population. The team used screening and detailed telephone interviews to identify persons 18 years or older with CFS-like illness and performed clinical examinations to further classify subjects with CFS on the basis of a standardized case definition. The overall prevalence of CFS was 235 per 100,000 persons. The illness was more than four times more common among women (373 per 100,000) than among men (83 per 100,000), and it was most common among white women 50 to 59 years of age (863 per 100,000). On average, the illness lasted about 7 years. Among those with CFS, only 16 percent had received a diagnosis and medical treatment for their illness. The 1-year CFS incidence was 180 per 100,000 persons. “These estimates are critical for helping public health officials, health maintenance organizations, and other insurance providers better understand the extent of CFS,” said Reeves. “They are also important in helping practicing physicians put CFS in a realistic context when examining and caring for patients,” he said. Dr. Reeves added that other studies based on data and blood samples collected from the Wichita study population are under way to evaluate the natural history of CFS and to identify potential molecular markers for use in diagnosing this illness. Additional information about CFS is available at www.cdc.gov/ncidod/diseases/cfs/index.htm. Source: CFIDS Association of America, online at www.cfids.org.


Please Discuss This Article:   Post a Comment 



[ Be the first to comment on this article ]




 
Free Chronic Fatigue Syndrome and Fibromyalgia Newsletters
Subscribe to
Our FREE
Newsletter
Subscribe Now!
Receive up-to-date ME/CFS & Fibromyalgia treatment and research news
 Privacy Guaranteed  |  View Archives

Save on Vitamins and Supplements

Featured Products

Optimized Curcumin Longvida® by ProHealth Optimized Curcumin Longvida® by ProHealth
Supports Cognition, Memory & Overall Health
FibroSleep™ by ProHealth FibroSleep™ by ProHealth
The All-in-One Natural Sleep Aid
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Vitamin D3 Extreme™ by ProHealth Vitamin D3 Extreme™ by ProHealth
50,000 IU Vitamin D3 - Prescription Strength

Natural Remedies

Irritable Bowel Syndrome: Unlocking the Secrets of Peppermint, Acacia and Fennel Irritable Bowel Syndrome: Unlocking the Secrets of Peppermint, Acacia and Fennel
The Brain Boosting and Fatigue Fighting B-12 The Brain Boosting and Fatigue Fighting B-12
The Revolutionary 'Good Fat' That Promotes Heart, Brain, Bone and Joint Health The Revolutionary 'Good Fat' That Promotes Heart, Brain, Bone and Joint Health
VIDEO: Healthy Eating and Fibromyalgia VIDEO: Healthy Eating and Fibromyalgia
Anti-Inflammatory Properties of Tart Cherry Anti-Inflammatory Properties of Tart Cherry

FIBROMYALGIA RESOURCES
What is Fibromyalgia?
Fibromyalgia 101
Fibromyalgia Symptoms
Fibromyalgia Treatments
| CFS RESOURCES
What is CFS?
ME/CFS 101
ME/CFS Symptoms
ME/CFS Treatments
| FORUMS
Fibromyalgia
ME/CFS
ADVANCED MEDICAL LABS
WHOLESALE  |  AFFILIATES
GUARANTEE
CONTACT US
PRIVACY
RSS
SITE MAP
ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus
Credit Card Processing